Consistently, such a subset of Treg cells were also identified in CRC, NSCLC, and hepatocellular carcinoma (HCC), with high activation and immune-suppressive potential as indicated by the high IL2R, inhibitory, and co-stimulatory scores (Supplementary Fig. 5c). The gene discussed is IL2RA; the disease is non-small cell lung carcinoma.